BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30070930)

  • 1. Pyrrolo[3,2-c]pyridine derivatives with potential inhibitory effect against FMS kinase: in vitro biological studies.
    El-Gamal MI; Oh CH
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1160-1166. PubMed ID: 30070930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based biological evaluation of a new bisamide FMS kinase inhibitor possessing pyrrolo[3,2-c]pyridine scaffold.
    El-Gamal MI; Abdel-Maksoud MS; El-Din MM; Yoo KH; Baek D; Oh CH
    Arch Pharm (Weinheim); 2014 Sep; 347(9):635-41. PubMed ID: 24942978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, biological evaluation, and in silico studies of novel pyridopyridine derivatives as anticancer candidates targeting FMS kinase.
    Sebastian A; Abu Rabah RR; Zaraei SO; Vunnam S; Sultan S; Anbar HS; El-Gamal R; Tarazi H; Sarg N; Alhamad DW; Al Shamma SA; Shahin AI; Omar HA; Al-Tel TH; El-Gamal MI
    Eur J Med Chem; 2024 Aug; 274():116557. PubMed ID: 38850857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel pyrrolo-pyridine/pyrimidine derivatives bearing pyridazinone moiety as c-Met kinase inhibitors.
    Wang LX; Liu X; Xu S; Tang Q; Duan Y; Xiao Z; Zhi J; Jiang L; Zheng P; Zhu W
    Eur J Med Chem; 2017 Dec; 141():538-551. PubMed ID: 29107421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel pyrrolo[2,3-b]pyridine derivatives targeting
    Abdel-Maksoud MS; Ali EMH; Ammar UM; Mersal KI; Yoo KH; Oh CH
    Bioorg Med Chem; 2020 Jun; 28(11):115493. PubMed ID: 32340792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Wang J; Tang Q; Wu C; Zhao Y; Zheng P
    Bioorg Med Chem; 2016 Apr; 24(8):1749-56. PubMed ID: 26964675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors.
    Tang Q; Wang L; Tu Y; Zhu W; Luo R; Tu Q; Wang P; Wu C; Gong P; Zheng P
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1680-4. PubMed ID: 26923692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and bioevaluation and doking study of 1H-pyrrolo[2,3-b]pyridine derivatives bearing aromatic hydrazone moiety as c-Met inhibitors.
    Wang W; Xu S; Duan Y; Liu X; Li X; Wang C; Zhao B; Zheng P; Zhu W
    Eur J Med Chem; 2018 Feb; 145():315-327. PubMed ID: 29331754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel FMS inhibitors.
    Kim YY; Choi J; Choi K; Park C; Kim YH; Suh KH; Ham YJ; Jang SY; Lee KH; Hwang KW
    Bioorg Med Chem Lett; 2019 Jan; 29(2):271-275. PubMed ID: 30522957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
    Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a new potent bisamide FMS kinase inhibitor.
    El-Gamal MI; Jung MH; Oh CH
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3216-8. PubMed ID: 20457522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety.
    Tang Q; Duan Y; Wang L; Wang M; Ouyang Y; Wang C; Mei H; Tang S; Xiong Y; Zheng P; Gong P; Zhu W
    Eur J Med Chem; 2018 Jan; 143():266-275. PubMed ID: 29197731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a series of 1H-pyrrolo[2,3-b]pyridine compounds as potent TNIK inhibitors.
    Yang B; Wu Q; Huan X; Wang Y; Sun Y; Yang Y; Liu T; Wang X; Chen L; Xiong B; Zhao D; Miao Z; Chen D
    Bioorg Med Chem Lett; 2021 Feb; 33():127749. PubMed ID: 33340663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
    Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
    Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony stimulating factor-1 receptor as a target for small molecule inhibitors.
    Mashkani B; Griffith R; Ashman LK
    Bioorg Med Chem; 2010 Mar; 18(5):1789-97. PubMed ID: 20156689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.
    Patnaik S; Stevens KL; Gerding R; Deanda F; Shotwell JB; Tang J; Hamajima T; Nakamura H; Leesnitzer MA; Hassell AM; Shewchuck LM; Kumar R; Lei H; Chamberlain SD
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3136-40. PubMed ID: 19394223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors.
    Liu N; Wang Y; Huang G; Ji C; Fan W; Li H; Cheng Y; Tian H
    Bioorg Chem; 2016 Apr; 65():146-58. PubMed ID: 26950400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of cytotoxic activity of a series of 1H-pyrrolo[2,3-b]pyridine derivatives as possible inhibitors of c-Met using molecular fingerprints.
    Damghani T; Mashayekh K; Pirhadi S; Firuzi O; Sharifi S; Edraki N; Khoshneviszadeh M; Avestan MS
    J Recept Signal Transduct Res; 2019 Aug; 39(4):295-303. PubMed ID: 31658862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of phosphorylation of the colony-stimulating factor-1 receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and other tyrosine kinase inhibitors.
    Guo J; Marcotte PA; McCall JO; Dai Y; Pease LJ; Michaelides MR; Davidsen SK; Glaser KB
    Mol Cancer Ther; 2006 Apr; 5(4):1007-13. PubMed ID: 16648572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors.
    Tian Y; Zhang T; Long L; Li Z; Wan S; Wang G; Yu Y; Hou J; Wu X; Zhang J
    Eur J Med Chem; 2018 Jan; 143():182-199. PubMed ID: 29174814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.